Articles
Slow, safe steps into the sticky new world

Slow, safe steps into the sticky new world

As the world of social media seems to move at an incredible pace, Emma D’Arcy looks at what has changed in pharma’s approach to it in the last year. In July 2009 I published the results of a series of interviews with pharmaceutical companies…

Articles
The market access myth

The market access myth

In the second of his two perspective pieces on pharma marketing, Chris Rose proposes that market access is a state of mind, not a role in itself. The idea that market access is a single role within the pharma business has evolved over recent years as the power of the “payor” has increased. This is a...

Articles
Lessons from the past, optimism for the future

Lessons from the past, optimism for the future

In our latest interview Paul Tunnah talks to Nigel Brooksby, a well known figure in UK pharma, to hear his advice for the next generation of industry leaders. One could be forgiven sometimes for thinking that there has never been a more challenging time to work in the pharma industry...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more